PAM
GOSS icon

Panagora Asset Management’s Gossamer Bio GOSS Stock Holding History

Panagora Asset Management’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$121K Buy
733,216
+263,270
+56% +$73.5K ﹤0.01% 1142
2026
Q1 		$154K Buy
469,946
+322,650
+219% +$507K ﹤0.01% 1118
2025
Q4 		$457K Buy
147,296
+117,397
+393% +$335K ﹤0.01% 884
2025
Q3 		$78.6K Buy
+29,899
New +$65.9K ﹤0.01% 1138

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Panagora Asset Management's GOSS Position: Q2 2026 in Review

Panagora Asset Management increased its Gossamer Bio (GOSS) stake by 56% in Q2 2026, buying an estimated $73.5K and bringing the position to 733,216 shares worth $121K. The position accounts for ﹤0.01% of the portfolio, ranked #1142.

Panagora Asset Management first reported a position in GOSS in Q3 2025 and has held it in 4 quarters since. The position peaked at $457K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Panagora Asset Management held 733,216 shares of Gossamer Bio worth $121K as of Q2 2026.
  • Panagora Asset Management bought 263,270 Gossamer Bio shares in Q2 2026, an estimated $73.5K.
  • Gossamer Bio made up ﹤0.01% of Panagora Asset Management's portfolio in Q2 2026, its #1142 holding.
  • Panagora Asset Management first reported a position in Gossamer Bio in Q3 2025 and has held it in 4 quarters since.
  • Panagora Asset Management's Gossamer Bio position peaked at $457K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Panagora Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.